Back to search

Article

SMCHD1 is a novel target for gene-activation therapy to treat Prader-Willi Syndrome

2026-05-14

Abstract excerpt

<h4>ABSTRACT</h4> Prader-Willi Syndrome (PWS) is a neurodevelopmental disorder caused by lack of gene expression from the active paternal allele at an imprinted gene cluster on chromosome 15. Current treatments have limited efficacy as they target individual symptoms rather than the underlying cause of disease. All patients preserve a normal, yet epigenetically-silenced, copy of the PWS cluster genes; activation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c230acf3-bcf9-5298-b3d6-5ed2e51f4149
DOI
10.64898/2026.05.13.725051
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SMCHD1 is a novel target for gene-activation therapy to treat Prader-Willi SyndromeDOI 10.64898/2026.05.13.725051
Select a neighboring publication to make it the new centre.